Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
4.720
+0.170 (3.74%)
May 28, 2026, 2:19 PM EDT - Market open
Atea Pharmaceuticals Market Cap
Atea Pharmaceuticals has a market cap or net worth of $377.73 million as of May 28, 2026. Its market cap has increased by 49.11% in one year.
Market Cap
377.73M
Enterprise Value
122.36M
1-Year Change
49.11%
Ranking
Category
Stock Price
$4.72
Market Cap Chart
Since the IPO on October 30, 2020, Atea Pharmaceuticals's market cap has decreased from $1.94B to $377.73M, a decrease of -80.51%. That is a compound annual growth rate of -25.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 364.12M | 30.55% |
| Dec 31, 2025 | 278.91M | -1.43% |
| Dec 31, 2024 | 282.95M | 11.19% |
| Dec 29, 2023 | 254.48M | -36.48% |
| Dec 30, 2022 | 400.61M | -46.08% |
| Dec 31, 2021 | 742.94M | -78.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 30, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| X4 Pharmaceuticals | 381.05M |
| Compass Therapeutics | 372.78M |
| Verastem | 372.58M |
| Vanda Pharmaceuticals | 372.24M |
| Puma Biotechnology | 360.37M |
| Larimar Therapeutics | 360.12M |
| Immuneering | 348.72M |
| Fennec Pharmaceuticals | 344.94M |